These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1110 related articles for article (PubMed ID: 7198010)
1. Antitumor activity and toxicity of cisplatin analogs. Rose WC; Schurig JE; Huftalen JB; Bradner WT Cancer Treat Rep; 1982 Jan; 66(1):135-46. PubMed ID: 7198010 [No Abstract] [Full Text] [Related]
2. Reduced antineoplastic activity in mice of cisplatin administered with high salt concentration in the vehicle. Aamdal S; Fodstad O; Kaalhus O; Pihl A J Natl Cancer Inst; 1984 Sep; 73(3):743-52. PubMed ID: 6590919 [TBL] [Abstract][Full Text] [Related]
3. Biological evaluation of mitoxantrone dihydrochloride synthesized by a new method. II. Comparison of Now 85/34 and Novantrone (Lederle) acute toxicity and antitumor activity. Matuszyk J; Kuśnierczyk H; Radzikowski C Arch Immunol Ther Exp (Warsz); 1989; 37(1-2):89-99. PubMed ID: 2619513 [TBL] [Abstract][Full Text] [Related]
4. Relative pulmonary toxicity and antitumor effects of two new bleomycin analogs, pepleomycin and tallysomycin A. Sikic BI; Siddik ZH; Gram TE Cancer Treat Rep; 1980; 64(4-5):659-67. PubMed ID: 6159079 [TBL] [Abstract][Full Text] [Related]
5. [Complex compounds of platinum in the chemotherapy of malignant tumors]. Presnov MA; Konovalova AL; Korol'chuk VP Vestn Akad Med Nauk SSSR; 1979; (2):68-80. PubMed ID: 105504 [No Abstract] [Full Text] [Related]
6. Antitumor activity of N-diazoacetyl derivatives of glycine and phenylalanine against P388 leukemia and B16 melanoma in mice. Sava G; Giraldi T; Baldini L Cancer Treat Rep; 1982 Jan; 66(1):179-81. PubMed ID: 6796268 [TBL] [Abstract][Full Text] [Related]
7. Chemotherapy studies on experimental mouse tumors. IX. French FA; Blanz EJ Cancer Chemother Rep 2; 1971 Apr; 2(1):177-97. PubMed ID: 5565535 [No Abstract] [Full Text] [Related]
8. Therapeutic response of human tumor xenografts in athymic mice to doxorubicin. Giuliani FC; Zirvi KA; Kaplan NO Cancer Res; 1981 Jan; 41(1):325-35. PubMed ID: 7448772 [TBL] [Abstract][Full Text] [Related]
9. [Synthesis of rubomycin 13-tert-butoxycarbonylhydrazone and the study of its antitumor action]. Povarov LS; Gol'dberg LE; Bazhanov VS; Olsuf'eva EN; Averbukh LA Antibiotiki; 1981 Nov; 26(11):813-6. PubMed ID: 6895688 [TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationships of the antitumor platinum coordination complexes. Connors TA; Cleare MJ; Harrap KR Cancer Treat Rep; 1979; 63(9-10):1499-502. PubMed ID: 498149 [No Abstract] [Full Text] [Related]
11. [The role of the mono-oxygenase system in realizing the biological effects of cisplatin]. Chekhun VF; Pel'kis FP; Kulik GI Vopr Onkol; 1991; 37(9-10):954-8. PubMed ID: 1842656 [TBL] [Abstract][Full Text] [Related]
12. Preclinical antitumor efficacy of the polyamine analogue N1, N11-diethylnorspermine administered by multiple injection or continuous infusion. Bernacki RJ; Oberman EJ; Seweryniak KE; Atwood A; Bergeron RJ; Porter CW Clin Cancer Res; 1995 Aug; 1(8):847-57. PubMed ID: 9816054 [TBL] [Abstract][Full Text] [Related]
13. [Clinico-morphological comparisons of the results of the combined treatment of tumors with platinum derivatives]. Shalimov SA; Keĭsevich LV; Nikishin LF; Trokhimenko EP; Evtushenko GV Vrach Delo; 1988 Jul; (7):79-82. PubMed ID: 3188478 [No Abstract] [Full Text] [Related]
14. Activity of 3 beta-hydroxy-13 alpha-amino-13,17-seco-5 alpha-androstan-17-oic-13,17-lactam-p-bis(2-chloroethyl)aminophenoxyacetate (NSC 294859) on experimental animal tumor and leukemia systems. Catsoulacos P Oncology; 1983; 40(4):290-2. PubMed ID: 6866424 [TBL] [Abstract][Full Text] [Related]
15. Failure of amygdalin to arrest B16 melanoma and BW5147 AKR leukemia. Hill GJ; Shine TE; Hill HZ; Miller C Cancer Res; 1976 Jun; 36(6):2102-7. PubMed ID: 1268862 [TBL] [Abstract][Full Text] [Related]
16. [Antidotal and antineoplastic properties of copper sulfate]. Syrkin AB; Chlenova EL Biull Eksp Biol Med; 1988 Apr; 105(4):477-9. PubMed ID: 3359035 [TBL] [Abstract][Full Text] [Related]
17. Markedly improved efficacy of edatrexate compared to methotrexate in a high-dose regimen with leucovorin rescue against metastatic murine solid tumors. Sirotnak FM; Otter GM; Schmid FA Cancer Res; 1993 Feb; 53(3):587-91. PubMed ID: 8425192 [TBL] [Abstract][Full Text] [Related]
18. In vivo antitumor activity and host toxicity of methoxymorpholinyl doxorubicin: role of cytochrome P450 3A. Quintieri L; Rosato A; Napoli E; Sola F; Geroni C; Floreani M; Zanovello P Cancer Res; 2000 Jun; 60(12):3232-8. PubMed ID: 10866316 [TBL] [Abstract][Full Text] [Related]
19. Combination of MIG (CXCL9) chemokine gene therapy with low-dose cisplatin improves therapeutic efficacy against murine carcinoma. Zhang R; Tian L; Chen LJ; Xiao F; Hou JM; Zhao X; Li G; Yao B; Wen YJ; Li J; Zhang L; Chen XC; Luo F; Peng F; Jiang Y; Wei YQ Gene Ther; 2006 Sep; 13(17):1263-71. PubMed ID: 16672984 [TBL] [Abstract][Full Text] [Related]
20. Effect of dose, schedule, and route of administration on the in vivo toxicity and antitumor activity of two activated sulfhydryl derivatives of cyclophosphamide. Ramonas LM; Erickson LC; Ringsdorf H; Zaharko DS Cancer Res; 1980 Oct; 40(10):3704-8. PubMed ID: 7438053 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]